Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
4,503,909
-
Total 13F shares
-
12,486,174
-
Share change
-
-2,780,731
-
Total reported value
-
$14,874,276
-
Price per share
-
$1.19
-
Number of holders
-
42
-
Value change
-
-$4,685,208
-
Number of buys
-
25
-
Number of sells
-
14
Institutional Holders of Cellectar Biosciences, Inc. - Common Shares (CLRB) as of Q2 2021
As of 30 Jun 2021,
Cellectar Biosciences, Inc. - Common Shares (CLRB) was held by
42 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
12,486,174 shares.
The largest 10 holders included
Consonance Capital Management LP, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, BOXER CAPITAL, LLC, BlackRock Inc., Maven Securities LTD, SABBY MANAGEMENT, LLC, GEODE CAPITAL MANAGEMENT, LLC, TWO SIGMA ADVISERS, LP, and GSA CAPITAL PARTNERS LLP.
This page lists
42
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.